Pharmacy and Poisons Board: Applications

Protocol No.	Study Title	Principal Investigator(s)	Name of Site / County	Pages	Clear
Application Submission Dates-to- clear!

#	Protocol No	Study Title	Investigator(s) & Site(s)
1.	ECCT/24/01/03	Sample Report The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under “Introduction” is given below. If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf). Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. p { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }	Principal Investigator(s) 1. Given Principal Name Principal Family Name Site(s) in Kenya Some Site Name	View
2.	ECCT/24/01/02	hh ddd	Principal Investigator(s) 1. some some some family Site(s) in Kenya some name	View
3.	ECCT/24/02/03	sample short title come here gjhsghjGHJGHJ	Principal Investigator(s) 1. given faammma Site(s) in Kenya some	View
4.	ECCT/24/01/01	Short Title Sample Title	Principal Investigator(s) 1. some name principal some name principal some name principal Site(s) in Kenya 1.	View
5.	ECCT/24/11/01	Testronimal Study Phase 2 Testronimal Study Phase 2	Principal Investigator(s) 1. Joel Investigator Site(s) in Kenya 1. (Kisumu county)	View

History
+
Request History
4 previous requests available
====
Session
+
Session
- Config(array)
  userAgent9c3d2c89526db53b7b69e8c9faa06145
  time1787007273
  countdown10
====
Request
+
Request

Cake Params
- plugin(null)
- controllerapplications
- actionindex
- named(array)
  sortstudy_title
  directionasc
  statusstopped
- pass(empty)
- isAjax(false)
- paging(array)
  Application(array)
  page1
  current5
  count5
  prevPage(false)
  nextPage(false)
  pageCount1
  order(array)
  Application.study_titleasc
  limit5
  options(array)
  order(array)
  Application.study_titleasc
  sortstudy_title
  directionasc
  paramTypenamed
Post data
- Application(array)
  status
Query string

No querystring data.

Cookie

To view Cookies, add CookieComponent to Controller

Current Route
- keys(array)
  0controller
  1action
- options(empty)
- defaults(array)
  plugin(null)
- template/:controller/:action/*
====

Sql Logs

default

Total Time: 11 ms
Total Queries: 9 queries

Query	Affected	Num. rows	Took (ms)	Actions
SELECT `TrialStatus`.`id` FROM `ctr`.`trial_statuses` AS `TrialStatus` WHERE `TrialStatus`.`name` = 'Stopped' LIMIT 1	1	1	0
SELECT `Application`.`id`, `Application`.`user_id`, `Application`.`application_id`, `Application`.`is_child`, `Application`.`trial_status_id`, `Application`.`total_sites`, `Application`.`abstract_of_study`, `Application`.`study_title`, `Application`.`laymans_summary`, `Application`.`short_title`, `Application`.`protocol_no`, `Application`.`reference_no`, `Application`.`version_no`, `Application`.`date_of_protocol`, `Application`.`study_drug`, `Application`.`disease_condition`, `Application`.`product_type_biologicals`, `Application`.`product_type_proteins`, `Application`.`product_type_immunologicals`, `Application`.`product_type_vaccines`, `Application`.`product_type_hormones`, `Application`.`product_type_toxoid`, `Application`.`product_type_chemical`, `Application`.`product_type_medical_device`, `Application`.`product_type_chemical_name`, `Application`.`product_type_medical_device_name`, `Application`.`comparator`, `Application`.`comparator_name`, `Application`.`comparator_registered`, `Application`.`comparator_countries`, `Application`.`ecct_not_applicable`, `Application`.`ecct_ref_number`, `Application`.`email_address`, `Application`.`applicant_covering_letter`, `Application`.`applicant_protocol`, `Application`.`applicant_patient_information`, `Application`.`applicant_investigators_brochure`, `Application`.`applicant_investigators_cv`, `Application`.`applicant_signed_declaration`, `Application`.`applicant_financial_declaration`, `Application`.`applicant_gmp_certificate`, `Application`.`applicant_indemnity_cover`, `Application`.`applicant_opinion_letter`, `Application`.`applicant_approval_letter`, `Application`.`applicant_statement`, `Application`.`applicant_participating_countries`, `Application`.`applicant_addendum`, `Application`.`applicant_fees`, `Application`.`applicant_complete_form`, `Application`.`applicant_impd`, `Application`.`applicant_prev_data`, `Application`.`applicant_stability_data`, `Application`.`applicant_analysis_cert`, `Application`.`applicant_pictorial_sample`, `Application`.`applicant_gcp_training`, `Application`.`applicant_dsmb_charter`, `Application`.`applicant_detailed_budget`, `Application`.`applicant_indemnity_pi`, `Application`.`applicant_practice_license`, `Application`.`applicant_registration_ctr`, `Application`.`applicant_pan_african`, `Application`.`applicant_hard_copies`, `Application`.`applicant_signed_checklist`, `Application`.`statistical_analysis_plan`, `Application`.`applicant_contractual_agreement`, `Application`.`declaration_applicant`, `Application`.`declaration_date1`, `Application`.`declaration_principal_investigator`, `Application`.`declaration_date2`, `Application`.`protocol_not_ai_generated`, `Application`.`placebo_present`, `Application`.`study_objectives`, `Application`.`principal_inclusion_criteria`, `Application`.`principal_exclusion_criteria`, `Application`.`primary_end_points`, `Application`.`scope_diagnosis`, `Application`.`scope_prophylaxis`, `Application`.`scope_therapy`, `Application`.`scope_safety`, `Application`.`scope_efficacy`, `Application`.`scope_pharmacokinetic`, `Application`.`scope_pharmacodynamic`, `Application`.`scope_bioequivalence`, `Application`.`scope_dose_response`, `Application`.`scope_pharmacogenetic`, `Application`.`scope_pharmacogenomic`, `Application`.`scope_pharmacoecomomic`, `Application`.`scope_others`, `Application`.`scope_others_specify`, `Application`.`trial_human_pharmacology`, `Application`.`trial_administration_humans`, `Application`.`trial_bioequivalence_study`, `Application`.`trial_other`, `Application`.`trial_other_specify`, `Application`.`trial_therapeutic_exploratory`, `Application`.`trial_therapeutic_confirmatory`, `Application`.`trial_therapeutic_use`, `Application`.`design_controlled`, `Application`.`site_capacity`, `Application`.`staff_numbers`, `Application`.`other_details_explanation`, `Application`.`other_details_regulatory_notapproved`, `Application`.`other_details_regulatory_approved`, `Application`.`other_details_regulatory_rejected`, `Application`.`other_details_regulatory_halted`, `Application`.`estimated_duration`, `Application`.`design_controlled_randomised`, `Application`.`design_controlled_open`, `Application`.`design_controlled_single_blind`, `Application`.`design_controlled_double_blind`, `Application`.`design_controlled_parallel_group`, `Application`.`design_controlled_cross_over`, `Application`.`design_controlled_other`, `Application`.`design_controlled_specify`, `Application`.`design_controlled_comparator`, `Application`.`design_controlled_other_medicinal`, `Application`.`design_controlled_placebo`, `Application`.`design_controlled_medicinal_other`, `Application`.`design_controlled_medicinal_specify`, `Application`.`single_site_member_state`, `Application`.`location_of_area`, `Application`.`single_site_physical_address`, `Application`.`single_site_contact_person`, `Application`.`single_site_telephone`, `Application`.`multiple_sites_member_state`, `Application`.`multiple_countries`, `Application`.`multiple_member_states`, `Application`.`number_of_sites`, `Application`.`multi_country_list`, `Application`.`data_monitoring_committee`, `Application`.`total_enrolment_per_site`, `Application`.`total_participants_worldwide`, `Application`.`population_less_than_18_years`, `Application`.`population_utero`, `Application`.`population_preterm_newborn`, `Application`.`population_newborn`, `Application`.`population_infant_and_toddler`, `Application`.`population_children`, `Application`.`population_adolescent`, `Application`.`population_above_18`, `Application`.`population_adult`, `Application`.`population_elderly`, `Application`.`gender_female`, `Application`.`gender_male`, `Application`.`subjects_healthy`, `Application`.`subjects_patients`, `Application`.`subjects_vulnerable_populations`, `Application`.`subjects_women_child_bearing`, `Application`.`subjects_women_using_contraception`, `Application`.`subjects_pregnant_women`, `Application`.`subjects_nursing_women`, `Application`.`subjects_emergency_situation`, `Application`.`subjects_incapable_consent`, `Application`.`subjects_specify`, `Application`.`subjects_others`, `Application`.`subjects_others_specify`, `Application`.`investigator1_given_name`, `Application`.`investigator1_middle_name`, `Application`.`investigator1_family_name`, `Application`.`investigator1_qualification`, `Application`.`investigator1_professional_address`, `Application`.`investigator1_telephone`, `Application`.`investigator1_email`, `Application`.`organisations_transferred_`, `Application`.`number_participants`, `Application`.`notification`, `Application`.`approval_date`, `Application`.`submitted`, `Application`.`deleted`, `Application`.`deleted_date`, `Application`.`deactivated`, `Application`.`date_submitted`, `Application`.`unsubmitted`, `Application`.`initial_date_submitted`, `Application`.`admin_stopped`, `Application`.`admin_stopped_reason`, `Application`.`approved`, `Application`.`approved_reason`, `Application`.`approved_date`, `Application`.`final_report`, `Application`.`implication_results`, `Application`.`quantity_imported`, `Application`.`quantity_dispensed`, `Application`.`quantity_destroyed`, `Application`.`quantity_exported`, `Application`.`balance_site`, `Application`.`final_date`, `Application`.`ecitizen_invoice`, `Application`.`modified`, `Application`.`created`, `Application`.`ai_content` FROM `ctr`.`applications` AS `Application` WHERE `Application`.`trial_status_id` = 4 AND `Application`.`submitted` = '1' AND `Application`.`deactivated` = '0' AND `Application`.`deleted` = '0' ORDER BY `Application`.`study_title` asc LIMIT 5	5	5	7	maybe slow
SELECT `InvestigatorContact`.`id`, `InvestigatorContact`.`application_id`, `InvestigatorContact`.`given_name`, `InvestigatorContact`.`middle_name`, `InvestigatorContact`.`family_name`, `InvestigatorContact`.`qualification`, `InvestigatorContact`.`professional_address`, `InvestigatorContact`.`telephone`, `InvestigatorContact`.`email`, `InvestigatorContact`.`investigator_role`, `InvestigatorContact`.`created`, `InvestigatorContact`.`modified` FROM `ctr`.`investigator_contacts` AS `InvestigatorContact` WHERE `InvestigatorContact`.`application_id` IN (4, 3, 7, 2, 124)	5	5	1	maybe slow
SELECT `SiteDetail`.`id`, `SiteDetail`.`application_id`, `SiteDetail`.`county_id`, `SiteDetail`.`site_name`, `SiteDetail`.`physical_address`, `SiteDetail`.`contact_details`, `SiteDetail`.`contact_person`, `SiteDetail`.`site_capacity`, `SiteDetail`.`misc`, `SiteDetail`.`created`, `SiteDetail`.`modified` FROM `ctr`.`site_details` AS `SiteDetail` WHERE `SiteDetail`.`application_id` IN (4, 3, 7, 2, 124)	5	5	2	maybe slow
SELECT `County`.`id`, `County`.`county_name`, `County`.`created`, `County`.`modified` FROM `ctr`.`counties` AS `County` WHERE `County`.`id` = 27	1	1	0
SELECT `County`.`id`, `County`.`county_name`, `County`.`created`, `County`.`modified` FROM `ctr`.`counties` AS `County` WHERE `County`.`id` = 42	1	1	0
SELECT `Sponsor`.`id`, `Sponsor`.`application_id`, `Sponsor`.`sponsor`, `Sponsor`.`sponsor_type`, `Sponsor`.`contact_person`, `Sponsor`.`address`, `Sponsor`.`telephone_number`, `Sponsor`.`fax_number`, `Sponsor`.`cell_number`, `Sponsor`.`email_address`, `Sponsor`.`created`, `Sponsor`.`modified` FROM `ctr`.`sponsors` AS `Sponsor` WHERE `Sponsor`.`application_id` IN (4, 3, 7, 2, 124)	4	4	0
SELECT COUNT(*) AS `count` FROM `ctr`.`applications` AS `Application` WHERE `Application`.`trial_status_id` = 4 AND `Application`.`submitted` = '1' AND `Application`.`deactivated` = '0' AND `Application`.`deleted` = '0'	1	1	1
SELECT `TrialStatus`.`id`, `TrialStatus`.`name` FROM `ctr`.`trial_statuses` AS `TrialStatus` WHERE 1 = 1	12	12	0

Query Explain:

Click an "Explain" link above, to see the query explanation.

====

Timer

Memory

Peak Memory Use 10.18 MB

Message	Memory use
Component initialization	2.43 MB
Controller action start	3.61 MB
Controller render start	4.58 MB
View render complete	5.07 MB

Timers

Total Request Time: 182 (ms)

Message	Time in ms	Graph
Core Processing (Derived from $_SERVER["REQUEST_TIME"])	79.90
Event: Controller.initialize	1.62
Event: Controller.startup	0.83
Controller action	45.68
Event: Controller.beforeRender	23.24
» Processing toolbar data	23.12
Rendering View	9.60
» Event: View.beforeRender	0.03
» Rendering APP/View/Applications/index.ctp	0.26
» » Rendering APP/View/Elements/google-recommend.ctp	0.05
» Rendering APP/View/Elements/application/public_index.ctp	5.02
» Event: View.afterRender	0.02
» Event: View.beforeLayout	0.02
» Rendering APP/View/Layouts/default.ctp	3.80
» » Rendering APP/View/Elements/google-analytics.ctp	0.07
Event: View.afterLayout	0.00

====

Log
+

Logs

There were no log entries made this request

====
Variables
+
View Variables
- trial_statuses(array)
 1Recruiting
 2Not yet recruiting
 3Suspended
 4Stopped
 5Completed
 6In follow-up
 7Analysing
 8Writing-up
 9Application withdrawn
 10Paused or preparation for extension of study
 11Revoked
 12Ongoing Closeout Phase
- applications(array)
 0(array)
 Application(array)
 id4
 user_id26
 application_id(null)
 is_child0
 trial_status_id4
 total_sites(null)
 abstract_of_study\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under “Introduction” is given below. \n\n \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n \n
 study_title\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under “Introduction” is given below. \n\n \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n \n
 laymans_summary\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under “Introduction” is given below. \n\n \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n \n
 short_titleSample Report
 protocol_noECCT/24/01/03
 reference_no(null)
 version_nov23
 date_of_protocol11-01-2024
 study_drugSome Drug Name
 disease_conditionSome Condition
 product_type_biologicals1
 product_type_proteins0
 product_type_immunologicals1
 product_type_vaccines0
 product_type_hormones0
 product_type_toxoid0
 product_type_chemical0
 product_type_medical_device0
 product_type_chemical_nameChemo Name
 product_type_medical_device_nameMedical Device
 comparatorNo
 comparator_name
 comparator_registered
 comparator_countries
 ecct_not_applicable0
 ecct_ref_number
 email_addressimeja@gmail.com
 applicant_covering_letter1
 applicant_protocol1
 applicant_patient_information1
 applicant_investigators_brochure1
 applicant_investigators_cv1
 applicant_signed_declaration1
 applicant_financial_declaration1
 applicant_gmp_certificate1
 applicant_indemnity_cover1
 applicant_opinion_letter1
 applicant_approval_letter1
 applicant_statement1
 applicant_participating_countries(null)
 applicant_addendum1
 applicant_fees1
 applicant_complete_form(null)
 applicant_impd1
 applicant_prev_data1
 applicant_stability_data1
 applicant_analysis_cert1
 applicant_pictorial_sample1
 applicant_gcp_training1
 applicant_dsmb_charter1
 applicant_detailed_budget1
 applicant_indemnity_pi1
 applicant_practice_license1
 applicant_registration_ctr(null)
 applicant_pan_african1
 applicant_hard_copies(null)
 applicant_signed_checklist1
 statistical_analysis_plan1
 applicant_contractual_agreement1
 declaration_applicantsome
 declaration_date110-01-2024
 declaration_principal_investigatoraomw
 declaration_date210-01-2024
 protocol_not_ai_generated0
 placebo_presentNo
 study_objectives\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under “Introduction” is given below. \n\n \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n \n
 principal_inclusion_criteria\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under “Introduction” is given below. \n\n \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n \n
 principal_exclusion_criteria\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under “Introduction” is given below. \n\n \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n \n
 primary_end_points\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under â€œIntroductionâ€ is given below. \n\n Â \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n Â \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n Â \n
 scope_diagnosis1
 scope_prophylaxis1
 scope_therapy1
 scope_safety1
 scope_efficacy1
 scope_pharmacokinetic1
 scope_pharmacodynamic0
 scope_bioequivalence1
 scope_dose_response1
 scope_pharmacogenetic1
 scope_pharmacogenomic1
 scope_pharmacoecomomic1
 scope_others0
 scope_others_specify
 trial_human_pharmacology0
 trial_administration_humans1
 trial_bioequivalence_study0
 trial_other0
 trial_other_specify
 trial_therapeutic_exploratory0
 trial_therapeutic_confirmatory1
 trial_therapeutic_use0
 design_controlledNo
 site_capacity(null)
 staff_numbers\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under â€œIntroductionâ€ is given below. \n\n Â \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n Â \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n Â \n
 other_details_explanation\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under “Introduction” is given below. \n\n \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n \n
 other_details_regulatory_notapproved\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under â€œIntroductionâ€ is given below. \n\n Â \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n Â \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n Â \n
 other_details_regulatory_approved\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under â€œIntroductionâ€ is given below. \n\n Â \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n Â \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n Â \n
 other_details_regulatory_rejected\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under â€œIntroductionâ€ is given below. \n\n Â \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n Â \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n Â \n
 other_details_regulatory_halted\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under â€œIntroductionâ€ is given below. \n\n Â \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n Â \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n Â \n
 estimated_duration12
 design_controlled_randomised
 design_controlled_open
 design_controlled_single_blind
 design_controlled_double_blind
 design_controlled_parallel_group
 design_controlled_cross_over
 design_controlled_other
 design_controlled_specify
 design_controlled_comparator
 design_controlled_other_medicinal
 design_controlled_placebo
 design_controlled_medicinal_other
 design_controlled_medicinal_specify
 single_site_member_stateYes
 location_of_areaSome Site Name
 single_site_physical_addressSome address
 single_site_contact_personSome Contact Person
 single_site_telephone254700432987
 multiple_sites_member_stateNo
 multiple_countriesNo
 multiple_member_states
 number_of_sites
 multi_country_list
 data_monitoring_committeeNo
 total_enrolment_per_site4
 total_participants_worldwide4
 population_less_than_18_yearsNo
 population_uteroNo
 population_preterm_newbornNo
 population_newbornNo
 population_infant_and_toddlerNo
 population_childrenNo
 population_adolescentNo
 population_above_18Yes
 population_adultYes
 population_elderlyNo
 gender_female1
 gender_male1
 subjects_healthyYes
 subjects_patientsNo
 subjects_vulnerable_populationsNo
 subjects_women_child_bearingNo
 subjects_women_using_contraceptionNo
 subjects_pregnant_womenNo
 subjects_nursing_womenNo
 subjects_emergency_situationNo
 subjects_incapable_consentNo
 subjects_specify
 subjects_othersNo
 subjects_others_specify
 investigator1_given_nameSample Given Name
 investigator1_middle_name
 investigator1_family_nameSample Family Name
 investigator1_qualificationQualification Sample
 investigator1_professional_addressSample Address
 investigator1_telephone254700321876
 investigator1_emailsample-email@gmail.com
 organisations_transferred_No
 number_participants4
 notification\n The introduction should open with remarks stating that this document is a research registry protocol. The registry that will be conducted in compliance with the protocol, Good Clinical Practices (GCP), International Conference on Harmonization (ICH) Guidelines (E6) for GCPs standards as adopted by the Food and Drug Administration (FDA), and associated Federal regulations, and all applicable institutional research requirements. The rest of the introduction is broken out into subsections. Example language for the first paragraph under “Introduction” is given below. \n\n \n\n If you state you are following GCP or other regulations, please be sure that you are familiar with these as the conduct of your research registry will be reviewed against these standards (<a href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf\">www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129515.pdf</a>).\n\n \n\n Sample Text: This document is a protocol for a human research registry. This registry is to be conducted according to US standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. \n<style type=\"text/css\">\np { line-height: 100%; text-align: left; orphans: 2; widows: 2; text-indent: 0.5in; margin-bottom: 0in; direction: ltr; background: transparent }p.western { font-family: \"Times New Roman\", serif; font-size: 12pt }p.cjk { font-family: \"Times New Roman\"; font-size: 12pt }p.ctl { font-family: \"Times New Roman\"; font-size: 12pt }a:visited { color: #800080; text-decoration: underline }a:link { color: #0000ff; text-decoration: underline }</style>\n\n \n
 approval_date10-06-2024
 submitted1
 deleted0
 deleted_date(null)
 deactivated0
 date_submitted18-01-2024
 unsubmitted1
 initial_date_submitted18-01-2024
 admin_stopped1
 admin_stopped_reasonTest stop reason
 approved0
 approved_reasonApplication Approved Here
 approved_date(null)
 final_report(null)
 implication_results(null)
 quantity_imported(null)
 quantity_dispensed(null)
 quantity_destroyed(null)
 quantity_exported(null)
 balance_site(null)
 final_date(null)
 ecitizen_invoice(null)
 modified2024-06-10 11:56:22
 created2024-01-11 11:38:02
 ai_content(null)
 InvestigatorContact(array)
 0(array)
 id4
 application_id4
 given_nameGiven Principal Name
 middle_name
 family_namePrincipal Family Name
 qualificationSample Qualification
 professional_addressPrincipal Address
 telephone0700432765
 emailprincipal-email@gmail.com
 investigator_roleprincipal
 created2024-01-11 11:46:03
 modified2024-01-18 15:27:00
 SiteDetail(array)
 0(array)
 id15
 application_id4
 county_id27
 site_name
 physical_address
 contact_details
 contact_person
 site_capacity(null)
 misc(null)
 created2013-01-25 14:55:21
 modified2024-01-18 15:27:00
 County(array)
 id27
 county_nameUasin Gishu
 created2012-06-15 10:25:15
 modified2012-06-15 10:25:15
 Sponsor(array)
 0(array)
 id3
 application_id4
 sponsorNational Institutes of Health
 sponsor_typeOthers
 contact_person
 address9000 Rockville Pike Bethesda, Maryland 20892
 telephone_number301-496-4000
 fax_number
 cell_number301-496-4000
 email_addressNIHinfo@od.nih.gov
 created2024-01-11 11:46:03
 modified2024-01-18 15:27:00
 1(array)
 Application(array)
 id3
 user_id17
 application_id(null)
 is_child0
 trial_status_id4
 total_sites(null)
 abstract_of_study\n jjjj\n
 study_title\n ddd\n
 laymans_summary\n hhhh\n
 short_titlehh
 protocol_noECCT/24/01/02
 reference_no(null)
 version_nov5
 date_of_protocol10-01-2024
 study_drug7
 disease_conditionyyyy
 product_type_biologicals1
 product_type_proteins0
 product_type_immunologicals1
 product_type_vaccines0
 product_type_hormones0
 product_type_toxoid0
 product_type_chemical1
 product_type_medical_device1
 product_type_chemical_namesome chemical name
 product_type_medical_device_namesome medical device name
 comparatorYes
 comparator_nameyy
 comparator_registeredyy
 comparator_countriesyyt
 ecct_not_applicable0
 ecct_ref_number
 email_addresskiprotich.japheth19@gmail.com
 applicant_covering_letter1
 applicant_protocol1
 applicant_patient_information1
 applicant_investigators_brochure1
 applicant_investigators_cv1
 applicant_signed_declaration1
 applicant_financial_declaration1
 applicant_gmp_certificate1
 applicant_indemnity_cover1
 applicant_opinion_letter1
 applicant_approval_letter1
 applicant_statement1
 applicant_participating_countries(null)
 applicant_addendum1
 applicant_fees1
 applicant_complete_form(null)
 applicant_impd1
 applicant_prev_data1
 applicant_stability_data1
 applicant_analysis_cert1
 applicant_pictorial_sample1
 applicant_gcp_training1
 applicant_dsmb_charter1
 applicant_detailed_budget1
 applicant_indemnity_pi1
 applicant_practice_license1
 applicant_registration_ctr(null)
 applicant_pan_african1
 applicant_hard_copies(null)
 applicant_signed_checklist1
 statistical_analysis_plan1
 applicant_contractual_agreement1
 declaration_applicantlocal contact
 declaration_date110-01-2024
 declaration_principal_investigatorsome national
 declaration_date210-01-2024
 protocol_not_ai_generated0
 placebo_presentYes
 study_objectives\n some data\n
 principal_inclusion_criteria\n some data\n
 principal_exclusion_criteria\n some data\n
 primary_end_points\n some data\n
 scope_diagnosis1
 scope_prophylaxis1
 scope_therapy1
 scope_safety1
 scope_efficacy1
 scope_pharmacokinetic1
 scope_pharmacodynamic1
 scope_bioequivalence1
 scope_dose_response1
 scope_pharmacogenetic1
 scope_pharmacogenomic1
 scope_pharmacoecomomic1
 scope_others0
 scope_others_specify
 trial_human_pharmacology1
 trial_administration_humans0
 trial_bioequivalence_study1
 trial_other0
 trial_other_specify
 trial_therapeutic_exploratory1
 trial_therapeutic_confirmatory0
 trial_therapeutic_use0
 design_controlledYes
 site_capacity(null)
 staff_numbers\n some capacity data here \n
 other_details_explanation\n some details\n
 other_details_regulatory_notapproved\n ssomw data\n
 other_details_regulatory_approved\n some data\n
 other_details_regulatory_rejected\n some sata\n
 other_details_regulatory_halted\n some data\n
 estimated_duration12
 design_controlled_randomisedYes
 design_controlled_openNo
 design_controlled_single_blindYes
 design_controlled_double_blindNo
 design_controlled_parallel_groupYes
 design_controlled_cross_overNo
 design_controlled_otherYes
 design_controlled_specifysome
 design_controlled_comparatorsome
 design_controlled_other_medicinalNo
 design_controlled_placeboYes
 design_controlled_medicinal_otherNo
 design_controlled_medicinal_specify
 single_site_member_stateYes
 location_of_areasome name
 single_site_physical_addresssome address
 single_site_contact_personcontact person
 single_site_telephone0700432543
 multiple_sites_member_stateNo
 multiple_countriesYes
 multiple_member_states4
 number_of_sites
 multi_country_listsome four country list
 data_monitoring_committeeYes
 total_enrolment_per_site150
 total_participants_worldwide300
 population_less_than_18_yearsYes
 population_uteroNo
 population_preterm_newbornYes
 population_newbornNo
 population_infant_and_toddlerYes
 population_childrenNo
 population_adolescentYes
 population_above_18Yes
 population_adultYes
 population_elderlyNo
 gender_female1
 gender_male1
 subjects_healthyYes
 subjects_patientsYes
 subjects_vulnerable_populationsYes
 subjects_women_child_bearingNo
 subjects_women_using_contraceptionYes
 subjects_pregnant_womenNo
 subjects_nursing_womenYes
 subjects_emergency_situationNo
 subjects_incapable_consentYes
 subjects_specifysome
 subjects_othersNo
 subjects_others_specify
 investigator1_given_nameyuyyuyu
 investigator1_middle_nameyuyyu
 investigator1_family_nametest
 investigator1_qualificationtest
 investigator1_professional_addresstest
 investigator1_telephone0700876543
 investigator1_emailtest@gmail.com
 organisations_transferred_Yes
 number_participants50
 notification\n some of the commnets here \n
 approval_date18-06-2024
 submitted1
 deleted0
 deleted_date(null)
 deactivated0
 date_submitted11-01-2024
 unsubmitted0
 initial_date_submitted(null)
 admin_stopped1
 admin_stopped_reasonhey
 approved0
 approved_reasonDone
 approved_date(null)
 final_report(null)
 implication_results(null)
 quantity_imported(null)
 quantity_dispensed(null)
 quantity_destroyed(null)
 quantity_exported(null)
 balance_site(null)
 final_date(null)
 ecitizen_invoice(null)
 modified2024-06-18 12:01:53
 created2024-01-11 05:35:23
 ai_content(null)
 InvestigatorContact(array)
 0(array)
 id3
 application_id3
 given_namesome
 middle_namesome
 family_namesome family
 qualificationqualification
 professional_addressprofession
 telephone0700345231
 emailsample@gmail.com
 investigator_roleprincipal
 created2024-01-11 05:44:23
 modified2024-01-11 09:09:59
 SiteDetail(array)
 0(array)
 id1640
 application_id3
 county_id(null)
 site_name
 physical_address
 contact_details
 contact_person
 site_capacity(null)
 misc(null)
 created2024-01-11 05:44:23
 modified2024-01-11 09:09:59
 County(empty)
 Sponsor(empty)
 2(array)
 Application(array)
 id7
 user_id29
 application_id(null)
 is_child0
 trial_status_id4
 total_sites(null)
 abstract_of_study\n kjahkjhjkhjk\n
 study_title\n gjhsghjGHJGHJ\n
 laymans_summary\n jhjkhkjhkjhkjk\n
 short_titlesample short title come here
 protocol_noECCT/24/02/03
 reference_no(null)
 version_nov4
 date_of_protocol22-02-2024
 study_drugsss
 disease_conditiondddd
 product_type_biologicals1
 product_type_proteins0
 product_type_immunologicals1
 product_type_vaccines0
 product_type_hormones0
 product_type_toxoid0
 product_type_chemical0
 product_type_medical_device0
 product_type_chemical_name
 product_type_medical_device_name
 comparatorYes
 comparator_namessss
 comparator_registered2
 comparator_countries22222
 ecct_not_applicable0
 ecct_ref_number
 email_addressjkiprotich@intellisoftkenya.com
 applicant_covering_letter1
 applicant_protocol1
 applicant_patient_information1
 applicant_investigators_brochure1
 applicant_investigators_cv1
 applicant_signed_declaration1
 applicant_financial_declaration1
 applicant_gmp_certificate1
 applicant_indemnity_cover1
 applicant_opinion_letter1
 applicant_approval_letter1
 applicant_statement1
 applicant_participating_countries(null)
 applicant_addendum1
 applicant_fees1
 applicant_complete_form(null)
 applicant_impd1
 applicant_prev_data1
 applicant_stability_data1
 applicant_analysis_cert1
 applicant_pictorial_sample1
 applicant_gcp_training1
 applicant_dsmb_charter1
 applicant_detailed_budget1
 applicant_indemnity_pi1
 applicant_practice_license1
 applicant_registration_ctr(null)
 applicant_pan_african1
 applicant_hard_copies(null)
 applicant_signed_checklist1
 statistical_analysis_plan1
 applicant_contractual_agreement1
 declaration_applicantffff
 declaration_date122-02-2024
 declaration_principal_investigatorsssss
 declaration_date215-02-2024
 protocol_not_ai_generated0
 placebo_presentNo
 study_objectives\n HGDHGDH\n
 principal_inclusion_criteria\n saFAGFGY\n
 principal_exclusion_criteria\n ASHUIYUIDI\n
 primary_end_points\n ahHDKHKJ\n
 scope_diagnosis1
 scope_prophylaxis1
 scope_therapy0
 scope_safety0
 scope_efficacy0
 scope_pharmacokinetic0
 scope_pharmacodynamic0
 scope_bioequivalence0
 scope_dose_response0
 scope_pharmacogenetic0
 scope_pharmacogenomic0
 scope_pharmacoecomomic0
 scope_others0
 scope_others_specify
 trial_human_pharmacology0
 trial_administration_humans0
 trial_bioequivalence_study0
 trial_other0
 trial_other_specify
 trial_therapeutic_exploratory0
 trial_therapeutic_confirmatory0
 trial_therapeutic_use1
 design_controlledNo
 site_capacity(null)
 staff_numbers\n ASASS\n
 other_details_explanation\n sddad\n
 other_details_regulatory_notapproved\n ddddddd\n
 other_details_regulatory_approved\n ddddd\n
 other_details_regulatory_rejected\n ddddddd\n
 other_details_regulatory_halted\n ddddddd\n
 estimated_durationdddd
 design_controlled_randomised
 design_controlled_open
 design_controlled_single_blind
 design_controlled_double_blind
 design_controlled_parallel_group
 design_controlled_cross_over
 design_controlled_other
 design_controlled_specify
 design_controlled_comparator
 design_controlled_other_medicinal
 design_controlled_placebo
 design_controlled_medicinal_other
 design_controlled_medicinal_specify
 single_site_member_stateYes
 location_of_areasome
 single_site_physical_addresssome
 single_site_contact_personsome
 single_site_telephone0700432321
 multiple_sites_member_stateNo
 multiple_countriesNo
 multiple_member_states
 number_of_sites
 multi_country_list
 data_monitoring_committeeNo
 total_enrolment_per_siteKJHJH
 total_participants_worldwideSSSS
 population_less_than_18_yearsYes
 population_uteroYes
 population_preterm_newbornYes
 population_newbornNo
 population_infant_and_toddlerYes
 population_childrenYes
 population_adolescentNo
 population_above_18Yes
 population_adultNo
 population_elderlyYes
 gender_female1
 gender_male1
 subjects_healthyNo
 subjects_patientsNo
 subjects_vulnerable_populationsNo
 subjects_women_child_bearingNo
 subjects_women_using_contraceptionNo
 subjects_pregnant_womenNo
 subjects_nursing_womenNo
 subjects_emergency_situationNo
 subjects_incapable_consentNo
 subjects_specify
 subjects_othersNo
 subjects_others_specify
 investigator1_given_namewwewe
 investigator1_middle_name
 investigator1_family_nameeeeee
 investigator1_qualificationeee
 investigator1_professional_addresseeeeee
 investigator1_telephone0700443322
 investigator1_emailsample@gmail.com
 organisations_transferred_Yes
 number_participantsdhkjhkjfhK
 notification\n dddddada\n
 approval_date28-02-2024
 submitted1
 deleted0
 deleted_date(null)
 deactivated0
 date_submitted22-02-2024
 unsubmitted1
 initial_date_submitted01-02-2024
 admin_stopped1
 admin_stopped_reasonhey
 approved0
 approved_reasonApproved
 approved_date(null)
 final_report(null)
 implication_results(null)
 quantity_imported(null)
 quantity_dispensed(null)
 quantity_destroyed(null)
 quantity_exported(null)
 balance_site(null)
 final_date(null)
 ecitizen_invoice303020
 modified2024-06-01 11:05:05
 created2024-01-17 13:27:23
 ai_content(null)
 InvestigatorContact(array)
 0(array)
 id9
 application_id7
 given_namegiven
 middle_name
 family_namefaammma
 qualificationmamama
 professional_addressaaa
 telephone0700554433
 emailsample@gmail.com
 investigator_roleprincipal
 created2024-02-22 01:39:23
 modified2024-02-22 02:11:48
 SiteDetail(array)
 0(array)
 id1644
 application_id7
 county_id(null)
 site_name
 physical_address
 contact_details
 contact_person
 site_capacity(null)
 misc(null)
 created2024-02-22 01:39:23
 modified2024-02-22 02:11:48
 County(empty)
 Sponsor(array)
 0(array)
 id8
 application_id7
 sponsorsdsdd
 sponsor_typeIndustry
 contact_person
 addressddddd
 telephone_number0700443322
 fax_number
 cell_number0700443322
 email_addresssample@gmail.com
 created2024-02-22 01:39:23
 modified2024-02-22 02:11:48
 3(array)
 Application(array)
 id2
 user_id29
 application_id(null)
 is_child0
 trial_status_id4
 total_sites2
 abstract_of_study\n Abstract\n
 study_title\n Sample Title\n
 laymans_summary\n Some Summary\n
 short_titleShort Title
 protocol_noECCT/24/01/01
 reference_no(null)
 version_nov12
 date_of_protocol09-01-2024
 study_drugName
 disease_conditionSome condition
 product_type_biologicals1
 product_type_proteins1
 product_type_immunologicals1
 product_type_vaccines1
 product_type_hormones0
 product_type_toxoid0
 product_type_chemical1
 product_type_medical_device1
 product_type_chemical_namechemical name
 product_type_medical_device_namemedical device
 comparatorYes
 comparator_nameSome
 comparator_registeredSome
 comparator_countriesSome
 ecct_not_applicable0
 ecct_ref_number
 email_addressjkiprotich@intellisoftkenya.com
 applicant_covering_letter1
 applicant_protocol1
 applicant_patient_information1
 applicant_investigators_brochure1
 applicant_investigators_cv1
 applicant_signed_declaration1
 applicant_financial_declaration1
 applicant_gmp_certificate1
 applicant_indemnity_cover1
 applicant_opinion_letter1
 applicant_approval_letter1
 applicant_statement1
 applicant_participating_countries(null)
 applicant_addendum1
 applicant_fees1
 applicant_complete_form(null)
 applicant_impd1
 applicant_prev_data1
 applicant_stability_data1
 applicant_analysis_cert1
 applicant_pictorial_sample1
 applicant_gcp_training1
 applicant_dsmb_charter1
 applicant_detailed_budget1
 applicant_indemnity_pi1
 applicant_practice_license1
 applicant_registration_ctr(null)
 applicant_pan_african1
 applicant_hard_copies(null)
 applicant_signed_checklist1
 statistical_analysis_plan1
 applicant_contractual_agreement1
 declaration_applicantsome
 declaration_date109-01-2024
 declaration_principal_investigatorsome
 declaration_date209-01-2024
 protocol_not_ai_generated0
 placebo_presentNo
 study_objectives\n objectives\n
 principal_inclusion_criteria\n inclusion\n
 principal_exclusion_criteria\n exclusion\n
 primary_end_points\n end points\n
 scope_diagnosis1
 scope_prophylaxis1
 scope_therapy1
 scope_safety1
 scope_efficacy1
 scope_pharmacokinetic1
 scope_pharmacodynamic1
 scope_bioequivalence1
 scope_dose_response1
 scope_pharmacogenetic1
 scope_pharmacogenomic1
 scope_pharmacoecomomic1
 scope_others0
 scope_others_specify
 trial_human_pharmacology1
 trial_administration_humans0
 trial_bioequivalence_study1
 trial_other0
 trial_other_specify
 trial_therapeutic_exploratory1
 trial_therapeutic_confirmatory0
 trial_therapeutic_use0
 design_controlledNo
 site_capacity(null)
 staff_numbers\n some capacity\n
 other_details_explanation\n some\n
 other_details_regulatory_notapproved\n some\n
 other_details_regulatory_approved\n some\n
 other_details_regulatory_rejected\n some\n
 other_details_regulatory_halted\n some\n
 estimated_duration3some
 design_controlled_randomised
 design_controlled_open
 design_controlled_single_blind
 design_controlled_double_blind
 design_controlled_parallel_group
 design_controlled_cross_over
 design_controlled_other
 design_controlled_specify
 design_controlled_comparator
 design_controlled_other_medicinal
 design_controlled_placebo
 design_controlled_medicinal_other
 design_controlled_medicinal_specify
 single_site_member_stateNo
 location_of_area
 single_site_physical_address
 single_site_contact_person
 single_site_telephone
 multiple_sites_member_stateNo
 multiple_countriesYes
 multiple_member_states4
 number_of_sites
 multi_country_listsome four states here
 data_monitoring_committeeYes
 total_enrolment_per_site30
 total_participants_worldwide50
 population_less_than_18_yearsYes
 population_uteroYes
 population_preterm_newbornNo
 population_newbornYes
 population_infant_and_toddlerNo
 population_childrenYes
 population_adolescentNo
 population_above_18Yes
 population_adultYes
 population_elderlyNo
 gender_female1
 gender_male1
 subjects_healthyYes
 subjects_patientsYes
 subjects_vulnerable_populationsYes
 subjects_women_child_bearingNo
 subjects_women_using_contraceptionYes
 subjects_pregnant_womenNo
 subjects_nursing_womenYes
 subjects_emergency_situationNo
 subjects_incapable_consentYes
 subjects_specifysome
 subjects_othersNo
 subjects_others_specify
 investigator1_given_namesome
 investigator1_middle_namesome
 investigator1_family_namesome
 investigator1_qualificationsome
 investigator1_professional_addresssome
 investigator1_telephone254700234871
 investigator1_emailsample@gmail.com
 organisations_transferred_No
 number_participants20
 notification\n None\n
 approval_date13-01-2025
 submitted1
 deleted0
 deleted_date(null)
 deactivated0
 date_submitted22-05-2024
 unsubmitted1
 initial_date_submitted22-05-2024
 admin_stopped1
 admin_stopped_reasonVillation
 approved2
 approved_reasonHey
 approved_date(null)
 final_report(null)
 implication_results(null)
 quantity_imported(null)
 quantity_dispensed(null)
 quantity_destroyed(null)
 quantity_exported(null)
 balance_site(null)
 final_date(null)
 ecitizen_invoice301439
 modified2025-02-13 09:04:41
 created2024-01-09 05:09:48
 ai_content(null)
 InvestigatorContact(array)
 0(array)
 id2
 application_id2
 given_namesome name principal
 middle_namesome name principal
 family_namesome name principal
 qualificationsome qualofication
 professional_addresssome address
 telephone254700282716
 emailsome@gmail.com
 investigator_roleprincipal
 created2024-01-09 05:37:44
 modified2024-06-25 08:22:28
 SiteDetail(array)
 0(array)
 id1639
 application_id2
 county_id(null)
 site_name
 physical_address
 contact_details
 contact_person
 site_capacity(null)
 misc(null)
 created2024-01-09 05:37:44
 modified2024-06-25 08:22:28
 County(empty)
 Sponsor(array)
 0(array)
 id14
 application_id2
 sponsorsome sponsor
 sponsor_typeIndustry
 contact_personsome contact person
 addressaddress
 telephone_number0700432422
 fax_number
 cell_number0700434343
 email_addresssponsor@gmail.com
 created2024-05-22 16:52:09
 modified2024-06-25 08:22:28
 4(array)
 Application(array)
 id124
 user_id26
 application_id(null)
 is_child0
 trial_status_id4
 total_sites2
 abstract_of_study\n Testronimal Study Phase 2\n
 study_title\n Testronimal Study Phase 2\n
 laymans_summary\n Layman SUmmary\n
 short_titleTestronimal Study Phase 2
 protocol_noECCT/24/11/01
 reference_no
 version_no1
 date_of_protocol12-11-2024
 study_drugTestronimal
 disease_conditionCancer
 product_type_biologicals1
 product_type_proteins0
 product_type_immunologicals1
 product_type_vaccines0
 product_type_hormones0
 product_type_toxoid0
 product_type_chemical1
 product_type_medical_device0
 product_type_chemical_nameEndo
 product_type_medical_device_name
 comparatorNo
 comparator_name
 comparator_registered
 comparator_countries
 ecct_not_applicable0
 ecct_ref_number
 email_addressjayoma@intellisoftkenya.com
 applicant_covering_letter1
 applicant_protocol1
 applicant_patient_information1
 applicant_investigators_brochure1
 applicant_investigators_cv1
 applicant_signed_declaration1
 applicant_financial_declaration1
 applicant_gmp_certificate1
 applicant_indemnity_cover1
 applicant_opinion_letter1
 applicant_approval_letter1
 applicant_statement1
 applicant_participating_countries(null)
 applicant_addendum1
 applicant_fees1
 applicant_complete_form(null)
 applicant_impd1
 applicant_prev_data1
 applicant_stability_data1
 applicant_analysis_cert1
 applicant_pictorial_sample1
 applicant_gcp_training1
 applicant_dsmb_charter1
 applicant_detailed_budget1
 applicant_indemnity_pi1
 applicant_practice_license1
 applicant_registration_ctr(null)
 applicant_pan_african1
 applicant_hard_copies(null)
 applicant_signed_checklist1
 statistical_analysis_plan1
 applicant_contractual_agreement1
 declaration_applicanttest
 declaration_date120-11-2024
 declaration_principal_investigatortest
 declaration_date220-11-2024
 protocol_not_ai_generated0
 placebo_presentNo
 study_objectives\n test\n
 principal_inclusion_criteria\n test\n
 principal_exclusion_criteria\n test\n
 primary_end_points\n test\n
 scope_diagnosis0
 scope_prophylaxis0
 scope_therapy1
 scope_safety0
 scope_efficacy0
 scope_pharmacokinetic0
 scope_pharmacodynamic0
 scope_bioequivalence0
 scope_dose_response0
 scope_pharmacogenetic1
 scope_pharmacogenomic0
 scope_pharmacoecomomic0
 scope_others0
 scope_others_specify
 trial_human_pharmacology1
 trial_administration_humans0
 trial_bioequivalence_study1
 trial_other0
 trial_other_specify
 trial_therapeutic_exploratory0
 trial_therapeutic_confirmatory1
 trial_therapeutic_use0
 design_controlledNo
 site_capacity(null)
 staff_numbers\n test\n
 other_details_explanation\n test\n
 other_details_regulatory_notapproved\n test\n
 other_details_regulatory_approved\n test\n
 other_details_regulatory_rejected\n test\n
 other_details_regulatory_halted\n test\n
 estimated_duration1year
 design_controlled_randomised
 design_controlled_open
 design_controlled_single_blind
 design_controlled_double_blind
 design_controlled_parallel_group
 design_controlled_cross_over
 design_controlled_other
 design_controlled_specify
 design_controlled_comparator
 design_controlled_other_medicinal
 design_controlled_placebo
 design_controlled_medicinal_other
 design_controlled_medicinal_specify
 single_site_member_stateNo
 location_of_area
 single_site_physical_address
 single_site_contact_person
 single_site_telephone
 multiple_sites_member_stateNo
 multiple_countriesYes
 multiple_member_states5
 number_of_sites
 multi_country_listtest
 data_monitoring_committeeYes
 total_enrolment_per_site2000
 total_participants_worldwide2000000
 population_less_than_18_yearsNo
 population_uteroNo
 population_preterm_newbornNo
 population_newbornNo
 population_infant_and_toddlerNo
 population_childrenNo
 population_adolescentNo
 population_above_18Yes
 population_adultYes
 population_elderlyNo
 gender_female1
 gender_male0
 subjects_healthyYes
 subjects_patientsNo
 subjects_vulnerable_populationsNo
 subjects_women_child_bearingNo
 subjects_women_using_contraceptionNo
 subjects_pregnant_womenNo
 subjects_nursing_womenNo
 subjects_emergency_situationNo
 subjects_incapable_consentNo
 subjects_specify
 subjects_othersNo
 subjects_others_specify
 investigator1_given_nameInvestigating
 investigator1_middle_name
 investigator1_family_name Pharmacist
 investigator1_qualificationMasters
 investigator1_professional_address67
 investigator1_telephone+254792837631
 investigator1_emailinvest@gmail.com
 organisations_transferred_No
 number_participants100000
 notification\n test\n
 approval_date21-11-2024
 submitted1
 deleted0
 deleted_date(null)
 deactivated0
 date_submitted20-11-2024
 unsubmitted1
 initial_date_submitted20-11-2024
 admin_stopped1
 admin_stopped_reasontest
 approved2
 approved_reasontest
 approved_date(null)
 final_report(null)
 implication_results(null)
 quantity_imported(null)
 quantity_dispensed(null)
 quantity_destroyed(null)
 quantity_exported(null)
 balance_site(null)
 final_date(null)
 ecitizen_invoice330895
 modified2025-01-14 12:41:33
 created2024-11-20 09:09:12
 ai_content(null)
 InvestigatorContact(array)
 0(array)
 id78
 application_id124
 given_nameJoel
 middle_name
 family_nameInvestigator
 qualificationMasters
 professional_addressP.O Box 381-3558,Accra
 telephone+254790129837
 emailjayoma@intellisoftkenya.com
 investigator_roleprincipal
 created2024-11-20 09:12:27
 modified2025-01-14 12:21:23
 SiteDetail(array)
 0(array)
 id96
 application_id124
 county_id42
 site_name
 physical_address
 contact_details
 contact_person
 site_capacity(null)
 misc(null)
 created2013-04-17 09:41:35
 modified2025-01-14 12:21:23
 County(array)
 id42
 county_nameKisumu
 created2012-06-15 10:27:02
 modified2012-06-15 10:27:02
 Sponsor(array)
 0(array)
 id31
 application_id124
 sponsorSponsor
 sponsor_typeIndustry
 contact_person
 addressAddress
 telephone_number+254782930397
 fax_number
 cell_number+254782930397
 email_addressslow@gmail.com
 created2024-11-20 09:12:27
 modified2025-01-14 12:21:23
- page_options(array)
 55
 1010
- redir
- $request->data(array)
 Application(array)
 status
- $this->validationErrors(array)
 Permission(empty)
 Aro(empty)
 Aco(empty)
 Application(empty)
 User(empty)
 TrialStatus(empty)
 InvestigatorContact(empty)
 Sponsor(empty)
 SiteDetail(empty)
 County(empty)
- Loaded Helpers(array)
 0Html
 1Form
 2Session
 3Text
 4Number
 5SimpleGraph
 6Paginator
 7DebugTimer
 8Toolbar
 9HtmlToolbar
====

Environment

App Constants

Constant	Value
MEDIA	'/var/www/ctr/app/webroot/media/'
MEDIA_STATIC	'/var/www/ctr/app/webroot/media/static/'
MEDIA_FILTER	'/var/www/ctr/app/webroot/media/filter/'
MEDIA_TRANSFER	'/var/www/ctr/app/webroot/media/transfer/'
MEDIA_URL	'media/'
MEDIA_STATIC_URL	'media/static/'
MEDIA_FILTER_URL	'media/filter/'
MEDIA_TRANSFER_URL	'media/transfer/'
HTTP_HOST	'45.79.161.190:8080'
HTTP_BASE	'http://45.79.161.190:8080'
HTTP_SELF	'/app/webroot/index.php'
HTTP_URI	'/applications/index/sort:study_title/direction:asc/status:stopped'
CHOWN_PUBLIC	(int) 504
LF	''
NL	''
CR	''
TB	''
BR	' '
WINDOWS	false
FORMAT_DB_DATETIME	'Y-m-d H:i:s'
FORMAT_DB_DATE	'Y-m-d'
FORMAT_DB_TIME	'H:i:s'
DEFAULT_DATETIME	'0000-00-00 00:00:00'
DEFAULT_DATE	'0000-00-00'
DEFAULT_TIME	'00:00:00'
FILES	'/var/www/ctr/app/files/'
LOCALE	'/var/www/ctr/app/locale/'
CLASS_USER	'User'
VALID_ALPHA	'/^[a-zA-Z]+$/'
VALID_ALPHA_UNDERSCORES	'/^[a-zA-Z_]+$/'
VALID_ALPHA_MINUS_UNDERSCORES	'/^[a-zA-Z_-]+$/'
VALID_ALPHA_WHITESPACES	'/^[a-zA-Z ]+$/'
VALID_ALPHANUMERIC_UNDERSCORES	'/^[\da-zA-Z_]+$/'
VALID_ALPHANUMERIC_MINUS_UNDERSCORES	'/^[\da-zA-Z_-]+$/'
VALID_ALPHANUMERIC_WHITESPACES	'/^[\da-zA-Z ]+$/'
VALID_ALPHANUMERIC_WHITESPACES_UNDERSCORES	'/^[\da-zA-Z _]+$/'
VALID_NUMERIC_UNDERSCORES	'/^[\d_]+$/'
VALID_NUMERIC_WHITESPACES	'/^[\d ]+$/'
VALID_NUMERIC_WHITESPACES_UNDERSCORES	'/^[\d _]+$/'
VALID_INTEGERS	'/^[\d]+$/'
FORMAT_NICE_YMDHMS	'd.m.Y, H:i:s'
FORMAT_NICE_YMDHM	'd.m.Y, H:i'
FORMAT_NICE_YM	'm.Y'
FORMAT_NICE_YMD	'd.m.Y'
FORMAT_NICE_MD	'd.m.'
FORMAT_NICE_D	'd'
FORMAT_NICE_W_NUM	'w'
FORMAT_NICE_W_ABBR	'D'
FORMAT_NICE_W_FULL	'l'
FORMAT_NICE_M	'm'
FORMAT_NICE_M_ABBR	'M'
FORMAT_NICE_M_FULL	'F'
FORMAT_NICE_Y_ABBR	'y'
FORMAT_NICE_Y	'Y'
FORMAT_NICE_HM	'H:i'
FORMAT_NICE_HMS	'H:i:s'
FORMAT_LOCAL_WA_YMDHMS	'%a, %d.%m.%Y, %H:%M:%S'
FORMAT_LOCAL_WF_YMDHMS	'%A, %d.%m.%Y, %H:%M:%S'
FORMAT_LOCAL_WA_YMDHM	'%a, %d.%m.%Y, %H:%M'
FORMAT_LOCAL_WF_YMDHM	'%A, %d.%m.%Y, %H:%M'
FORMAT_LOCAL_YMDHMS	'%d.%m.%Y, %H:%M:%S'
FORMAT_LOCAL_YMDHM	'%d.%m.%Y, %H:%M'
FORMAT_LOCAL_YMD	'%d.%m.%Y'
FORMAT_LOCAL_MD	'%d.%m.'
FORMAT_LOCAL_D	'%d'
FORMAT_LOCAL_W_NUM	'%w'
FORMAT_LOCAL_W_ABBR	'%a'
FORMAT_LOCAL_W_FULL	'%A'
FORMAT_LOCAL_M	'%m'
FORMAT_LOCAL_M_ABBR	'%b'
FORMAT_LOCAL_M_FULL	'%B'
FORMAT_LOCAL_Y_ABBR	'%y'
FORMAT_LOCAL_YMS_ABBR	'%d.%m.%y'
FORMAT_LOCAL_Y	'%Y'
FORMAT_LOCAL_H	'%H'
FORMAT_LOCAL_S	'%S'
FORMAT_LOCAL_HM	'%H:%M'
FORMAT_LOCAL_HMS	'%H:%M:%S'
CHAR_LESS	'<'
CHAR_GREATER	'>'
CHAR_QUOTE	'"'
CHAR_APOSTROPHE	'''
CHAR_ARROWS	'»'
CHAR_ARROWS_R	'»'
CHAR_ARROWS_L	'«'
CHAR_AVERAGE	'Ø'
CHAR_INFIN	'∞'
CHAR_MILL	'‰'
CHAR_PLUSMN	'±'
CHAR_HELLIP	'…'
CHAR_CIRCA	'≈'
CHAR_CHECKBOX_EMPTY	'☐]'
CHAR_CHECKBOX_MAKRED	'☑'
CHAR_CHECKMARK	'✓'
CHAR_CHECKMARK_BOLD	'✔'
CHAR_BALLOT	'✗'
CHAR_BALLOT_BOLD	'✘'
CHAR_ABOUT	'≈'
CHAR_RPIME	'′'
CHAR_DOUBLE_RPIME	'″'

CakePHP Constants

Constant	Value
APP	'/var/www/ctr/app/'
APP_DIR	'app'
APPLIBS	'/var/www/ctr/app/Lib/'
CACHE	'/var/www/ctr/app/tmp/cache/'
CAKE	'/var/www/ctr/lib/Cake/'
CAKE_CORE_INCLUDE_PATH	'/var/www/ctr/lib'
CORE_PATH	'/var/www/ctr/lib/'
CAKE_VERSION	'2.2.2'
CSS	'/var/www/ctr/app/webroot/css/'
CSS_URL	'css/'
DS	'/'
FULL_BASE_URL	'http://45.79.161.190:8080'
IMAGES	'/var/www/ctr/app/webroot/img/'
IMAGES_URL	'img/'
JS	'/var/www/ctr/app/webroot/js/'
JS_URL	'js/'
LOGS	'/var/www/ctr/app/tmp/logs/'
ROOT	'/var/www/ctr'
TESTS	'/var/www/ctr/app/Test/'
TMP	'/var/www/ctr/app/tmp/'
VENDORS	'/var/www/ctr/vendors/'
WEBROOT_DIR	'webroot'
WWW_ROOT	'/var/www/ctr/app/webroot/'

PHP Environment

Environment Variable	Value
Php Version	'5.6.40-63+ubuntu18.04.1+deb.sury.org+2'
Redirect Redirect Status	'200'
Redirect Status	'200'
Http Accept	'/'
Http User Agent	'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)'
Http Accept Encoding	'gzip, br, zstd, deflate'
Http Host	'45.79.161.190:8080'
Http Via	'1.1 squid-proxy-5b96dc6d46-nrc5k (squid/6.13)'
Http X Forwarded For	'10.9.62.171'
Http Cache Control	'max-age=259200'
Http Connection	'keep-alive'
Path	'/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin:/snap/bin'
Server Signature	' Apache/2.4.41 (Ubuntu) Server at 45.79.161.190 Port 8080 '
Server Software	'Apache/2.4.41 (Ubuntu)'
Server Name	'45.79.161.190'
Server Addr	'45.79.161.190'
Server Port	'8080'
Remote Addr	'216.73.216.79'
Document Root	'/var/www/ctr'
Request Scheme	'http'
Context Prefix	''
Context Document Root	'/var/www/ctr'
Server Admin	'webmaster@localhost'
Script Filename	'/var/www/ctr/app/webroot/index.php'
Remote Port	'1128'
Redirect Url	'/app/webroot/applications/index/sort:study_title/direction:asc/status:stopped'
Gateway Interface	'CGI/1.1'
Server Protocol	'HTTP/1.1'
Request Method	'GET'
Query String	''
Request Uri	'/applications/index/sort:study_title/direction:asc/status:stopped'
Script Name	'/app/webroot/index.php'
Php Self	'/app/webroot/index.php'
Request Time Float	(float) 1786978473.488
Request Time	(int) 1786978473

====

Include
+
Included Files

Include Paths
- 0/var/www/ctr/app/Plugin/Media/Lib/mm/src
- 1/var/www/ctr/lib
- 3/usr/share/php
- 4-> /var/www/ctr/lib/Cake/
Included Files
- core(array)
  Behavior(array)
  0CORE/Model/Behavior/TreeBehavior.php
  1CORE/Model/Behavior/ContainableBehavior.php
  2CORE/Model/Behavior/AclBehavior.php
  Cache(array)
  0CORE/Cache/Cache.php
  1CORE/Cache/Engine/FileEngine.php
  2CORE/Cache/CacheEngine.php
  Component(array)
  0CORE/Controller/Component/AclComponent.php
  1CORE/Controller/Component/Acl/DbAcl.php
  2CORE/Controller/Component/Acl/AclInterface.php
  3CORE/Controller/Component/AuthComponent.php
  4CORE/Controller/Component/RequestHandlerComponent.php
  5CORE/Controller/Component/SessionComponent.php
  6CORE/Controller/Component/PaginatorComponent.php
  Config(array)
  0CORE/Config/routes.php
  1CORE/Config/config.php
  Controller(array)
  0CORE/Controller/Controller.php
  1CORE/Controller/ComponentCollection.php
  2CORE/Controller/Component.php
  Datasource(array)
  0CORE/Model/Datasource/CakeSession.php
  1CORE/Model/Datasource/Database/Mysql.php
  2CORE/Model/Datasource/DboSource.php
  3CORE/Model/Datasource/DataSource.php
  Error(array)
  0CORE/Error/exceptions.php
  1CORE/Error/ErrorHandler.php
  I18n(array)
  0CORE/I18n/I18n.php
  1CORE/I18n/L10n.php
  Log(array)
  0CORE/Log/CakeLog.php
  1CORE/Log/LogEngineCollection.php
  2CORE/Log/Engine/FileLog.php
  3CORE/Log/Engine/BaseLog.php
  4CORE/Log/CakeLogInterface.php
  Model(array)
  0CORE/Model/ConnectionManager.php
  1CORE/Model/Permission.php
  2CORE/Model/Model.php
  3CORE/Model/BehaviorCollection.php
  4CORE/Model/Aro.php
  5CORE/Model/AclNode.php
  6CORE/Model/Aco.php
  7CORE/Model/ModelBehavior.php
  Network(array)
  0CORE/Network/CakeRequest.php
  1CORE/Network/CakeResponse.php
  Other(array)
  0CORE/bootstrap.php
  1CORE/basics.php
  2CORE/Core/App.php
  3CORE/Core/Configure.php
  4CORE/Core/CakePlugin.php
  5CORE/Event/CakeEventListener.php
  6CORE/Event/CakeEvent.php
  7CORE/Event/CakeEventManager.php
  8CORE/Core/Object.php
  Routing(array)
  0CORE/Routing/Dispatcher.php
  1CORE/Routing/Filter/AssetDispatcher.php
  2CORE/Routing/DispatcherFilter.php
  3CORE/Routing/Filter/CacheDispatcher.php
  4CORE/Routing/Router.php
  5CORE/Routing/Route/CakeRoute.php
  6CORE/Routing/Route/PluginShortRoute.php
  Utility(array)
  0CORE/Utility/Hash.php
  1CORE/Utility/Inflector.php
  2CORE/Utility/ObjectCollection.php
  3CORE/Utility/Debugger.php
  4CORE/Utility/String.php
  5CORE/Utility/ClassRegistry.php
  6CORE/Utility/Set.php
  7CORE/Utility/Sanitize.php
  View(array)
  0CORE/View/HelperCollection.php
- app(array)
  Behavior(array)
  0APP/Model/Behavior/SoftDeleteBehavior.php
  Config(array)
  0APP/Config/core.php
  1APP/Config/bootstrap.php
  2APP/Config/routes.php
  3APP/Config/database.php
  Controller(array)
  0APP/Controller/ApplicationsController.php
  1APP/Controller/AppController.php
  Model(array)
  0APP/Model/AppModel.php
  1APP/Model/Application.php
  2APP/Model/User.php
  3APP/Model/TrialStatus.php
  4APP/Model/InvestigatorContact.php
  5APP/Model/Sponsor.php
  6APP/Model/SiteDetail.php
  7APP/Model/County.php
  Other(array)
  0APP/webroot/index.php
- plugins(array)
  CakePdf(array)
  Config(array)
  0CakePdf/Config/bootstrap.php
  1CakePdf/Config/routes.php
  CakeResque(array)
  Config(array)
  0CakeResque/Config/bootstrap.php
  Plugin(array)
  0CakeResque/Lib/CakeResque.php
  1CakeResque/vendor/kamisama/php-resque-ex/lib/Resque.php
  2CakeResque/vendor/kamisama/php-resque-ex/lib/Resque/Event.php
  3CakeResque/vendor/kamisama/php-resque-ex/lib/Resque/Exception.php
  DebugKit(array)
  Component(array)
  0DebugKit/Controller/Component/ToolbarComponent.php
  Plugin(array)
  0DebugKit/Lib/DebugMemory.php
  1DebugKit/Lib/Panel/HistoryPanel.php
  2DebugKit/Lib/DebugPanel.php
  3DebugKit/Lib/Panel/SessionPanel.php
  4DebugKit/Lib/Panel/RequestPanel.php
  5DebugKit/Lib/Panel/SqlLogPanel.php
  6DebugKit/Lib/Panel/TimerPanel.php
  7DebugKit/Lib/Panel/LogPanel.php
  8DebugKit/Lib/Log/Engine/DebugKitLog.php
  9DebugKit/Lib/Panel/VariablesPanel.php
  10DebugKit/Lib/Panel/EnvironmentPanel.php
  11DebugKit/Lib/Panel/IncludePanel.php
  12DebugKit/Lib/DebugTimer.php
  Media(array)
  Config(array)
  0Media/Config/bootstrap.php
  Plugin(array)
  0Media/Lib/mm/src/Mime/Type.php
  1Media/Lib/mm/src/Mime/Type/Magic/Adapter/Fileinfo.php
  2Media/Lib/mm/src/Mime/Type/Magic/Adapter.php
  3Media/Lib/mm/src/Mime/Type/Glob/Adapter/Freedesktop.php
  4Media/Lib/mm/src/Mime/Type/Glob/Adapter.php
  5Media/Lib/mm/src/Media/Process.php
  6Media/Lib/mm/src/Media/Info.php
  Search(array)
  Component(array)
  0Search/Controller/Component/PrgComponent.php
  Behavior(array)
  0Search/Model/Behavior/SearchableBehavior.php
  Shim(array)
  Config(array)
  0Shim/Config/bootstrap.php
  Tools(array)
  Config(array)
  0Tools/Config/bootstrap.php
====

Clinical Trial Applications: Filter, Search, and view applications {lang: 'en-GB'}

Request History

Session

Request

Cake Params

Post data

Query string

Cookie

Current Route

Sql Logs

default

Total Time: 11 ms Total Queries: 9 queries

Query Explain:

Memory

Timers

Logs

View Variables

App Constants

CakePHP Constants

PHP Environment

Included Files

Include Paths

Included Files

Clinical Trial Applications: Filter, Search, and view applications

Total Time: 11 ms
Total Queries: 9 queries